Key Points
- SVP Erica Rossitto sold 3,500 HCA shares at an average price of $505.81, totaling about $1.77 million. After the sale, she owned 13,426 shares, a 20.68% reduction in her holdings.
- HCA reported quarterly EPS of $7.22, beating the $6.65 consensus estimate, and revenue of $19.85 billion, above forecasts and up 3.6% year over year.
- The company announced a quarterly dividend of $0.78 per share, equivalent to $3.12 annually and a 0.6% yield.
HCA Healthcare, Inc. (NYSE:HCA - Get Free Report) SVP Erica Rossitto sold 3,500 shares of the firm's stock in a transaction dated Tuesday, November 10th. The shares were sold at an average price of $505.81, for a total transaction of $1,770,335.00. Following the completion of the sale, the senior vice president owned 13,426 shares of the company's stock, valued at $6,791,005.06. This trade represents a 20.68% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.
HCA Healthcare Stock Performance
HCA Healthcare stock opened at $504.27 on Wednesday. The stock has a 50-day simple moving average of $447.20 and a 200 day simple moving average of $445.64. The stock has a market capitalization of $105.34 billion, a P/E ratio of 16.71, a PEG ratio of 1.69 and a beta of 1.11. HCA Healthcare, Inc. has a 52 week low of $353.99 and a 52 week high of $556.52.
HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Tuesday, October 27th. The company reported $7.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.65 by $0.57. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The firm had revenue of $19.85 billion for the quarter, compared to analyst estimates of $19.33 billion. During the same quarter in the prior year, the company earned $6.96 earnings per share. The business's revenue for the quarter was up 3.6% compared to the same quarter last year. Research analysts forecast that HCA Healthcare, Inc. will post 30.15 earnings per share for the current year.
HCA Healthcare Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 29th. Investors of record on Tuesday, December 15th will be issued a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, December 15th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare's payout ratio is presently 10.34%.
Institutional Trading of HCA Healthcare
Several hedge funds have recently added to or reduced their stakes in HCA. MidFirst Bank bought a new stake in HCA Healthcare in the 2nd quarter valued at $28,000. Clearstead Trust LLC bought a new position in HCA Healthcare during the 2nd quarter worth $29,000. Latitude Advisors LLC acquired a new stake in shares of HCA Healthcare during the third quarter worth $32,000. Delos Wealth Advisors LLC acquired a new stake in shares of HCA Healthcare during the second quarter worth $35,000. Finally, Laurel Wealth Advisors LLC bought a new stake in shares of HCA Healthcare in the third quarter valued at about $40,000. 62.73% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
HCA has been the subject of several research reports. TD Cowen raised their price target on HCA Healthcare from $460.00 to $486.00 and gave the company a "buy" rating in a report on Wednesday, October 28th. Morgan Stanley decreased their price objective on shares of HCA Healthcare from $425.00 to $380.00 and set an "underweight" rating on the stock in a report on Monday, July 27th. Leerink Partners reissued an "outperform" rating and issued a $492.00 price objective on shares of HCA Healthcare in a research report on Friday, September 18th. Bank of America lifted their target price on shares of HCA Healthcare from $450.00 to $500.00 and gave the stock a "neutral" rating in a report on Wednesday, October 28th. Finally, Wells Fargo & Company upped their price target on shares of HCA Healthcare from $381.00 to $468.00 and gave the company an "equal weight" rating in a research note on Monday, November 2nd. Sixteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, HCA Healthcare has a consensus rating of "Moderate Buy" and a consensus price target of $480.13.
Check Out Our Latest Analysis on HCA
HCA Healthcare Company Profile
(
Get Free Report)
HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine. The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices. Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
